RVTY Q1 2026 Earnings EPS Edges Past Estimates Revenue Details Not Disclosed CVBF Q1 2026 Earnings EPS Misses Estimates Amid Challenging Interest Rate Environment Marker Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Biotech Advances Pipeline IRIX Q1 2026 Earnings EPS Surprises to the Upside Despite Limited Revenue Disclosure UXIN Q1 2025 Earnings Narrowing Loss Reported Stock Edges Lower HELE Q1 2026 Earnings EPS Beats Estimates by 154 Stock Rises